Analysis of appropriate position of everolimus using two dimensional chart: multi-institutional retrospective study

Analysis of appropriate position of everolimus using two dimensional chart: multi-institutional retrospective study - Examination of everolimus using two dimensional chart

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032569

Enrollment

150

Registered

2018-05-14

Start date

2017-10-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hormone receptor positive HER2 negative advanced metastatic breast cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. ER positive and/or PgR positive 2. HER2 negative 3. patient with administration of everolimus for more than 1 week

Exclusion criteria

Exclusion criteria: nothing

Design outcomes

Primary

Measure	Time frame
Time to treatment failure	—

Countries

Japan

Contacts

Public ContactYuichiro Kikawa

Kobe city medical center general hospital Breast surgery

u-1ro@kcho.jp078-302-4321

Outcome results